While cannabinoids offer a potential alternative for refractory chronic pain, optimal use requires personalized dosing and ...

As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Danielle started struggling with painful chronic migraines at the age of 10 — it was hard for her and her family as their ...

Many people with ongoing medical conditions experience more symptoms during the winter. Here's why, and what you can do.

Tilt, which launched on February 4, was founded by 21-year-old Aerin Glazer, who (like over 51 million other Americans) lives ...

Presentations Included First Human Data on EVA™, Saluda's Automated SCS Programming Platform MINNEAPOLIS, Feb. 5, 2025 ...

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

Botox shots have increased in recent years, not just for cosmetic purposes but also for medical applications. The therapy consists of a purified type of neurotoxin, produced by the bacterium ...

Among patients with chronic insomnia, transcutaneous auricular vagus nerve stimulation improves sleep quality and is safe and effective.

Like yoga mats with coils, these electromagnetic frequency-emitting devices are trending and doctors love them. Here’s the ...